ClinicalTrials.govpublic full text
Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
migraine, rimegepant, triptans, acute treatment of migraine, survey, cross-sectional design, national health and wellness survey (nhws), patient-reported outcomes, treatment satisfaction, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874030
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.